gw medicine notes - george washington university 2016.pdf · volume 20, issue 5 may 2016 gw...

4
“So it goes.” No one but Kurt Vonnegut could say so much by saying so little. The last month, I have been thinking about these three words, which was a repeated refrain in Slaugh- terhouse-Five. To me it means that stuff happens and then you have to move on. I am sure there are hundreds or at least another interpretation of what he meant by these three words, but I have mine. If you have yours, keep it to yourself as I get enough emails. Reimbursement of drugs given in the office, such as chemotherapy, by Medicare often (frequently) doesn’t cover the cost of the drug. As if that wasn’t obnoxious enough, now CMS is proposing to influence patient care by further decreasing the payment to physicians so that docs will choose lower cost drugs. In other words, if you want to recoup the cost of the medication you are delivering you had better choose a cheap drug. Take Rituximab as an example. Rituximab is a monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is used to treat diseases which are characterized by excessive numbers of B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders. The World Health Organization considers it an essential medication. And it is very expensive but overall, given the efficacy of extending life, it appears to be cost effective. In 2013, Med- icare spent $1.5 billion on this drug for fewer than 70,000 patients. In fact, Medicare spent more than $6 billion on just 5 drugs for cancer, rheumatoid arthritis and macular degenera- tion. It is no mystery why CMS would want to decrease their expenditures on pharmaceuticals. When the Bush administration wanted to secure pharma's acquiescence to a prescription drug benefit for Medicare (Part D), they included a provision in the legislation that prevents Medi- care from using its large purchasing power to negotiate prices. Obama promised to repeal this restriction and Sen. Al Franken, D-Minn., has introduced a bill that would repeal the ban on negotiations, but it is stalled (blocked) in the Senate Finance Committee. The Congressional Budget Office estimates that allowing CMS to negotiate drug prices for all Medicare benefi- ciaries could save the program $155 billion over ten years. All private insurers and even Medicaid and the VA can negotiate discounts. How is this not insanity or a reflection of the clout of big pharma (redundant)? Because negotiating for lower prices is being stymied by the Republicans, physicians are be- ing pressured to save money for Medicare by choosing less expensive therapies. I thought the Republicans campaigned against rationing of health care? (What is next; Death Panels?) If only someone from the Senate Finance Committee would step up and say “please give me the less expensive therapy even though it may be less effective.” Would anyone really use a less effective drug on a patient for a life-altering or life-threatening disease? Is anyone still won- dering why physicians are opting out of Medicare? Papa Bush stuck us with Clarence Thomas and little Bush with a large Medicare drug bill. Can’t imagine why JEB! wasn’t taken seriously. “So it goes.” May 2016 Volume 20, Issue 5 GW Medicine Notes A Monthly Publication of the GW Department of Medicine From the Chairman The Department of Medicine, mourns the pass- ing of former dean and professor emeritus, Rob- ert I. Keimowitz, M.D. Dr. Keimowitz joined the SMHS faculty in 1970. Among his many leadership roles at GW SMHS, he served as assistant dean for admissions, dean for academic affairs and, from 1989 to 1998, as dean. He was dedicated to the practice of medicine and remained an active member of the GW MFA after he retired as dean. Until very recently, Dr. Keimowitz supervised medical students in the clinical setting as a preceptor and continued to see patients at the MFA. There is no one I respected more at GW than Bob; for his intellect, his loyalty and his complete devotion to his students and patients. Very few are excellent administrators, educators as well as excellent clinicians, but Bob was all three. He was the most honest person I knew and didn't 'suffer fools lightly' especially when it came to social injustice. I had the great honor of recommending him for emeritus status and encouraged him to continue his clinical work until his illness no longer allowed. Bob and I had many great battles over the years and he could give as well as he could take. He was a unique individual who touched many lives including mine. I will greatly miss him, his long emails, our long conversations and his continuing quest to make me a better person. I don’t know if he succeeded but he never gave up trying. He enjoyed the challenge. Alan G. Wasserman, M.D. Robert I. Keimowitz, M.D SAVE THE DATE END-OF-THE-YEAR PARTY FRIDAY, JUNE 10th RITZ CARLTON HOTEL

Upload: others

Post on 18-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: GW Medicine Notes - George Washington University 2016.pdf · Volume 20, Issue 5 May 2016 GW Medicine Notes A Monthly Publication of the GW Department of Medicine From the Chairman

“So it goes.” No one but Kurt Vonnegut could say so much by saying so little. The last

month, I have been thinking about these three words, which was a repeated refrain in Slaugh-

terhouse-Five. To me it means that stuff happens and then you have to move on. I am sure

there are hundreds or at least another interpretation of what he meant by these three words,

but I have mine. If you have yours, keep it to yourself as I get enough emails.

Reimbursement of drugs given in the office, such as chemotherapy, by Medicare often

(frequently) doesn’t cover the cost of the drug. As if that wasn’t obnoxious enough, now

CMS is proposing to influence patient care by further decreasing the payment to physicians so

that docs will choose lower cost drugs. In other words, if you want to recoup the cost of the

medication you are delivering you had better choose a cheap drug.

Take Rituximab as an example. Rituximab is a monoclonal antibody against the protein

CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys

B cells and is used to treat diseases which are characterized by excessive numbers of B cells.

This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.

The World Health Organization considers it an essential medication. And it is very expensive

but overall, given the efficacy of extending life, it appears to be cost effective. In 2013, Med-

icare spent $1.5 billion on this drug for fewer than 70,000 patients. In fact, Medicare spent

more than $6 billion on just 5 drugs for cancer, rheumatoid arthritis and macular degenera-

tion.

It is no mystery why CMS would want to decrease their expenditures on pharmaceuticals.

When the Bush administration wanted to secure pharma's acquiescence to a prescription drug

benefit for Medicare (Part D), they included a provision in the legislation that prevents Medi-

care from using its large purchasing power to negotiate prices. Obama promised to repeal this

restriction and Sen. Al Franken, D-Minn., has introduced a bill that would repeal the ban on

negotiations, but it is stalled (blocked) in the Senate Finance Committee. The Congressional

Budget Office estimates that allowing CMS to negotiate drug prices for all Medicare benefi-

ciaries could save the program $155 billion over ten years. All private insurers and even

Medicaid and the VA can negotiate discounts. How is this not insanity or a reflection of the

clout of big pharma (redundant)?

Because negotiating for lower prices is being stymied by the Republicans, physicians are be-

ing pressured to save money for Medicare by choosing less expensive therapies. I thought the

Republicans campaigned against rationing of health care? (What is next; Death Panels?) If

only someone from the Senate Finance Committee would step up and say “please give me the

less expensive therapy even though it may be less effective.” Would anyone really use a less

effective drug on a patient for a life-altering or life-threatening disease? Is anyone still won-

dering why physicians are opting out of Medicare?

Papa Bush stuck us with Clarence Thomas and little Bush with a large Medicare drug bill.

Can’t imagine why JEB! wasn’t taken seriously. “So it goes.”

May 2016 Volume 20, Issue 5

GW Medicine Notes A Monthly Publication of the GW Department of Medicine

From the Chairman The Department of Medicine, mourns the pass-

ing of former dean and professor emeritus, Rob-

ert I. Keimowitz, M.D.

Dr. Keimowitz joined the SMHS faculty in 1970.

Among his many leadership roles at GW SMHS,

he served as assistant dean for admissions, dean

for academic affairs and, from 1989 to 1998, as

dean.

He was dedicated to the practice of medicine

and remained an active member of the GW MFA

after he retired as dean. Until very recently, Dr.

Keimowitz supervised medical students in the

clinical setting as a preceptor and continued to

see patients at the MFA.

There is no one I respected more at GW than

Bob; for his intellect, his loyalty and his complete

devotion to his students and patients. Very few

are excellent administrators, educators as well as

excellent clinicians, but Bob was all three. He was

the most honest person I knew and didn't 'suffer

fools lightly' especially when it came to social

injustice.

I had the great honor of recommending him for

emeritus status and encouraged him to continue

his clinical work until his illness no longer allowed.

Bob and I had many great battles over the years

and he could give as well as he could take. He

was a unique individual who touched many lives

including mine. I will greatly miss him, his long

emails, our long conversations and his continuing

quest to make me a better person. I don’t know

if he succeeded but he never gave up trying. He

enjoyed the challenge.

Alan G. Wasserman, M.D.

Robert I. Keimowitz, M.D

SAVE THE DATE

END-OF-THE-YEAR PARTY

FRIDAY, JUNE 10th

RITZ CARLTON HOTEL

Page 2: GW Medicine Notes - George Washington University 2016.pdf · Volume 20, Issue 5 May 2016 GW Medicine Notes A Monthly Publication of the GW Department of Medicine From the Chairman

Department of Medicine May 2016 Grand Rounds

Medicine Team Contacts

Page 2 GW Medicine Notes

WHITE TEAM (202) 715-5669 YELLOW TEAM (202) 715-6041 GREEN TEAM (202) 715-6062 RED TEAM (202) 715-6039 BLUE TEAM (202) 715-6156 SILVER TEAM (202) 715-6040 PURPLE TEAM (202) 715-6042 GOLD TEAM (202) 715-6044

ADMITTING RESIDENT 741-0161 pager

Resident Lecture Series May 2016 Noon Conference

MAR 1 Journal Club MAR 2 GME Core Lecture

MAR 3 Medicine Grand Rounds MAR 4 Chairman’s Rounds

MAR 7 “Oral Health in Primary Care”- Dr. Pierre Carter MAR 8 Mortality & Morbidity-

Drs. Dana Kay and JoeDelio MAR 9 “Genetic Screening”- Dr. Macri and Andrew Nance, MS4 MAR 10 Medicine Grand Rounds

MAR 11 Chairman’s Rounds MAR 14 TBD

MAR 15 “Chronic Disease Prevention and Management: A Dentist’s Perspective”- Dr. Pierre Carter

MAR 16 GME Core Lecture MAR 17 Medicine Grand Rounds

MAR 18 Chairman’s Rounds MAR 21 “Special Topics in Adult Oral Healthcare: Geriatrics,

Oropharyngeal Cancer, Infectious Disease Prevention, and Women’s Health”- Dr. Pierre Carter MAR 22 Clinicopathologic Conference-

Drs. Abeer Alfaraj and Rami Al Sharif MAR 23 TBD

MAR 24 Medicine Grand Rounds MAR 25 Chairman’s Rounds MAR 28 TBD MAR 29 TBD

MAR 30 TBD MAR 31 TBD

MAY 5 Zimmerman Endowed Lecture

“Non-Alcoholic Steatohepatosis”

Zobair Younossi, MD, MPH

Professor of Medicine, Virginia Commonwealth

University, Inova Campus

Affiliate Professor of Biomedical Sciences, George

Mason University

Vice President, Research for Inova Health System

Executive Director, Center for Liver Diseases

Inova Fairfax Hospital

MAY 12 AOA LECTURE: “Medicine's Next Fron-

tier: The Power of Public Health & Physician

Activism”

Leana Wen, MD

Baltimore City Health Commissioner

Director, Patient-Centered Care Research

Emergency Medicine Department

GW Medical Faculty Associates

MAY 19 “QI GRAND ROUNDS”

Quality Improvement Groups

Internal Medicine Residents

GW Medical Faculty Associates

MAY 26 Rodham Institute Grand Rounds

“ Medical Education and Health Equity in DC”

Jehan (Gigi) El-Bayoumi, MD

Professor of Medicine

Division of General Internal Medicine

Department of Medicine

Founding Director, Rodham Institute

GW Medical Faculty Associates

The George Washington University Medical Center (GWUMC) is accredited by

the Accreditation Council for Continuing Medical Education (ACCME) to

sponsor continuing medical education for physicians. GWUMC designates this continuing medical education activity on an hour-for-hour basis in Category I of

the Physician’s Recognition Award of the American Medical Association.

(AMA).

Cardiology Grand Rounds 5:00 PM, Ross Hall, Room # 104

MAY 4 Mortality & Morbidity Conference MAY 11 Nehal Mehta, MD Clinical Professor of Medicine, GWU Chief, Section of Inflammation and Cardiometabolic Diseases National Heart, Lung, and Blood Institute Inflammation and the Heart MAY 18 Tim McCaffrey, PhD Professor of Medicine and Microbiology, Infectious Disease and Tropical Medicine Director, Division of Genomic Medicine GW Medical Faculty Associates Genomics in CV Medicine MAY 25 Ramesh Singh, MD Cardiac Vascular And Thoracic Surgery Associates INOVA Hospital Mechanical Circulatory Support

MAY 2 TBD MAY 3 Journal Club MAY 4 GME Core Lecture MAY 5 Medicine Grand Rounds MAY 6 Chairman’s Rounds MAY 9 “Mystery Diagnosis Case”- Dr. Richard Simons MAY 10 TBD MAY 11 “AML”- Dr. Khaled El-Shami MAY 12 Medicine Grand Rounds MAY 13 Chairman’s Rounds MAY 16 TBD MAY 17 Clinicopathologic Conference- Drs. Vani Pyda and Justin Ertle MAY 18 TBD MAY 19 Medicine Grand Rounds MAY 20 Chairman’s Rounds MAY 23 TBD MAY 24 Clinicopathologic Conference- Drs. Cory Bolinger and Rami Alsubail MAY 25 TBD MAY 26 Medicine Grand Rounds MAY 27 Chairman’s Rounds MAY 30 TBD MAY 31 TBD

Page 3: GW Medicine Notes - George Washington University 2016.pdf · Volume 20, Issue 5 May 2016 GW Medicine Notes A Monthly Publication of the GW Department of Medicine From the Chairman

GW Medicine Notes Page 3

Faculty Recognition House Staff Recognition

Shant Ayanian, MD, Hospital Medicine, as he was one of

the 2016 Golden Apple Award Recipients.

Dr. Gurusher Panjrath, Cardiology, on being invited to

serve as a member of the Academic Cardiology Section

Leadership Council for the American College of Cardiology.

Dr. Juan Reyes, Hospital Medicine, as he was a selected

recipient of the GW SMHS Office of Diversity and Inclusion

Retention Initiative conference sponsorship. He was select-

ed for sponsored attendance to the 2016 AAMC Minority

Faculty Career Development Seminar in Texas.

Dr. Alex Mechaber, former resident and chief resident, Sen-

ior Associate Dean for Undergraduate Medical Education at

the University of Miami, for being awarded the endowed

Dr. Bernard J. Fogel Chair in Medical Education.

Dr. Farzana Walcott, General Internal Medicine, on being

selected to receive a 2016 Young Investigator Award from

the American Society of Clinical Oncology (ASCO).

Congratulations!!

GME Updates: Congratulations… to the Endocrinology division for their continued ACGME accreditation. Congratulations to all involved for the official ABIM board

pass rate at 100% for the year. Our three year rolling pass rate is 92%.

Way to go!

GW Research Day: Congratulations to Joseph Delio, MD, PGY 2, as he was awarded the GME Research, Quality Improve-ment Award for his work, “Improving adherence to the Unit-ed States Preventive Services Task Force screening and immun-ization guidelines among residents at the internal medicine clinic with the GWU MFA group” Kudos to these internal medicine residents for their presen-tations at the GW Residency Fellowship in Health Policy meeting in March. The following residents presented: Drs. Tina Chee, PGY2, Jim Howard, PGY3, Nishant Magar, PGY3, Caitlin Biedron, PGY2, Katie Cramer, PGY3, and Sara Pike, PGY2. Kudos… to Hind Rafei, PGY1, who was awarded the hospital’s 4 South Doctor of the month award! Congratulations… to Dr. Suneeta Ganji, PGY3, as she will be celebrated at the American College of Physicians Internal Medicine Meeting in May as a Young Achiever. This is a great achievement, especially for a young achiever. Congratulations… to all 2nd year fellows in Endocrinology who all had posters presented at the Endocrinology Society in April. Internal Medicine Residents have had a very successful win-ter with numerous poster presentations accepted for national meetings: 6 posters at the National ACP Meeting 8 posters at the Society of General Internal Medicine Na-

tional Meeting 4 posters at the National Society of Hospital Medicine

Meeting 3 posters and one podium presentation at the American

College of Medical Quality National Meeting 1 poster at the American Thoracic Society National Meet-

ing 5 posters at the Society of General Internal Medicine Mid-

Atlantic Regional Meeting. These 4 internal medicine residents were involved in re-search along with Gastroenterology faculty and presented posters at GW research day. Gregory Piech, PGY 1 Justin Ertle, PGY 2 Samah Nassereddine, PGY 3 Alexis Pavle, PGY 2

Chairman’s Rounds GWU Hospital Auditorium, 12:00 Noon

All Faculty Invited to Attend MAY 6 Tyler Basen MAY 13 Dr. Jacob Elkon Dr. Samah Nasreddine MAY 20 Dr. Amani Alameer Dr. Shuo Chen MAY 27 Dr. Brandon Rieders Dr. Yasir Alfi

Page 4: GW Medicine Notes - George Washington University 2016.pdf · Volume 20, Issue 5 May 2016 GW Medicine Notes A Monthly Publication of the GW Department of Medicine From the Chairman

The George Washington University Medical Faculty Associates

Department of Medicine, Suite 8-416

2150 Pennsylvania Avenue, NW

GW Medicine Notes Page 4

Rheumatology Academic Conference Schedule MAY 2016

2300 M Street, Suite 3-332

8 AM– 11:30 AM Questions? Call (202) 741-2488

MAY 5: Journal Club Sam Serafi, MD MAY 5: Didactic Sessions MAY 12 : Radiology Conference Dr. Kathleen Brindle, Associate Professor of Radiology Chief, Musculoskeletal Radiology NOTE LOCATION: GWU Hospital Radiology Conference Room MAY 12: Didactic Sessions MAY 19 : Intra-City Rheumatology Grand Rounds NOTE LOCATION: GWU NOTE TIME: 7:30 AM MAY 19 : Faculty Meeting MAY 26 “Osteoporosis and Inflammation” Mandana Hashefi, MD MAY 26: Didactic Sessions

Kudos and Congratulations Kudos… to Dr. Cecilia Kim, Geriatrics fellow, on receiving a patient

compliment, “I have the best doctor ever… she gives excellent care for my

heart disease.”

Kudos… to Dr. Tania Alchalabi, Geriatrics, on a great teaching evalu-

ation from one of her students “…was fantastic to work with. Her respect

for her patients as well as her interest in their health and well-being is

something to be emulated.”

Kudos… to Dr. Marco Mercader, Cardiology, a colleague writes, “He

went significantly above and beyond what I would ever expect from a physi-

cian to ensure the safety and allay the fears of one of our mutual patients…I

commend his professionalism and teamwork.”

Kudos… to Dr. Christina Prather, Geriatrics and Palliative Care, on

receiving a letter of praise from the hospital, “ you have been incredibly

helpful to our patients, thank you!”

Condolences

To the family of Dr. Paul Silver, General Internal Medicine, on the passing

of his mother in March. Our thoughts and prayers are with you.

To the family of Dr. Gail Povar, Clinical Professor of Medicine, on the pass-

ing of her mother in March. Our thoughts and prayers are with you.

See you next month! The Editor